External Seminar
No event found!
Past External Seminars
October 2025
Prof.ssa Paola Chiarugi – ““Extracellular nutrients driving metastatic organotropism in prostate cancer: when tumor cells go hunting the most favorable environment”
https://www.sbsc.unifi.it/vp-214-gruppo-chiarugi.html Paola Chiarugi nasce a Firenze il 5 settembre 1965. 1989- si laurea in Scienze Biologiche presso l’ Università degli Studi di Firenze il 12 dicembre con la votazione di 110 /110 e lode e menzione di encomio della commissione di laurea, presso il Dipartimento di Biologia Animale e Genetica. 1890- Abilitazione alla professione di […]
May 2025
Prof.ssa Zoya Ignitova – “Unlocking the unreachable: harnessing tRNA therapeutics for rare genetic diseases”
Prof.ssa Zoya Ignitova, Biochemistry and Molecular Biology, University of Hamburg, Hamburg, Germany
Dott. Isidro Cortes-Ciriano – “Computational cancer genome analysis at a national scale: insights into cancer onset and evolution”
Dott. Isidro Cortes-Ciriano European Bioinformatics Institute -European Molecular Biology Laboratory (EMBL-EBI) Hinxton, Cambridge, UK My laboratory focuses on the development of computational methods to study the mechanisms underpinning cancer genome complexityand evolution, and to harness novel technologies applicable inclinical settings to improve early cancer detection and treatment selection. In this talk, I will first discuss […]
December 2024
Prof.ssa Chiara Ambrogio – “Targeting KRAS: achievements and drawbacks”
Associate Professor, Dept. of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center (MBC) University of Torino, Italy
November 2024
Dott. Daniele Fachinetti – “Mechanisms that control genome integrity at human centromeres”
DOTT. DANIELE FACHINETTI Molecular Mechanisms of Chromosome Dynamics, Institut Curie, Paris, France Maintenance of genome integrity and of a correct chromosome karyotype is crucial for human health. Indeed, both an abnormal number of chromosomes and structural chromosome alterations, aneuploidies, are hallmarks of many human cancers. In response to aneuploidy, cells elicit a surveillance mechanism that […]
Prof. Elisa Giovannetti – “Anticancer therapies stopped at the pancreas”: Unraveling the biological and pharmacological foundations of resistance in pancreatic cancer”
PROF.SSA ELISA GIOVANNETTI Amsterdam University Medical Center (UMC), The Netherlands Elisa Giovannetti, MD, PhD. received her M.D. and Ph.D. with full marks and from the University of Pisa, Italy, in 2000 and 2007, respectively. Between 2001 and 2004, she contributed to translational studies on pharmacogenetics as clinical fellow in Pharmacology in the Department of Oncology […]
October 2024
Dott.ssa Ilaria Elia – “The metabolic cross-talk between T cells and cancer cells in melanomaderived metastasis”
Prof. ILARIA ELIA Laboratory of Metabolic Regulation of Cell Function Department of Cellular and Molecular Medicine, KU Leuven Assistant Professor, KU Leuven Dr. Ilaria Elia is an assistant professor at KU Leuven, leading the laboratory of Metabolic RegulaAon of Cell FuncAon since 2021. Dr. Elia conducted her Ph.D. studies in the laboratory of Prof. […]
Dott. Frank Slack – “Toward microRNA-based therapeutics in cancer”
Frank Slack, Ph.D., is Director of the Harvard Medical School Initiative for RNA Medicine hosted at Beth Israel Deaconess Medical Center (BIDMC). He is also the Shields Warren Mallinckrodt Professor of Pathology at Harvard Medical School. Frank Slack received his B.Sc. from the University of Cape Town in South Africa, before completing his Ph.D. in […]
Dott.ssa Michèle Studer – “In vitro and in vivo modelling of an emerging neurodevelopmental disorder”
Research Director – Université Cote d’Azur (UCA), CNRS, Inserm, Institut de Biologie Valrose, iBV Nice, France
September 2024
WEBINAR – Prof. Eleftheria Zeggini – “Translational genomics of complex traits”
PROF. Eleftheria Zeggini Director – Institute of Translational Genomics Department Helmholtz Zentrum München – German Research Center Eleftheria works in the field of Translational Genomics. Her team develops and applies robust statistical and computational tools to integrate information gleaned from deep molecular, genomics and epidemiological approaches to address important biomedical research challenges. “In 2018 […]
June 2024
Prof. Thorsten Hornemann – “Sphingolipids in Neurological Disorders”
Prof. Thorsten Hornemann Institute of Clinical Chemistry, University Hospital, Zurich, Switzerland Abstract: Sphingolipids play a critical role in the pathophysiology of nerve disorders including leukodystrophies, the Hereditary Sensory and Autonomic Neuropathy Type 1 (HSAN1), Amyotrophic Lateral Sclerosis (ALS) and the Diabetic Sensory Neuropathy. They modulate cellular signaling pathways, which are crucial in […]
Prof. Yuri Bozzi – “Somatosensory differences and neuroinflammation in genetic models of autism spectrum disorders”
Yuri Bozzi, Ph.D. Director Center for Mind/Brain Sciences (CIMeC) – University of Trento yuri.bozzi@unitn.it Sensory differences are a common feature in autism spectrum disorders (ASD). Similarly, sensory deficits have been described in mice lacking ASD-associated genes. We investigated somatosensory abnormalities in Cntnap2 and Shank3b mutant mice, two well-characterized mouse models of ASD. Our work showed […]
No event found!
